Leos Eye Drop contains Loteprednol etabonate 0.5% w/v, a corticosteroid indicated for the treatment of inflammatory conditions of the eye, including allergic conjunctivitis, postoperative inflammation, and anterior uveitis. Loteprednol etabonate is a corticosteroid with potent anti-inflammatory properties that works by inhibiting multiple inflammatory mediators, thereby reducing swelling, redness, and irritation. The formulation is designed for topical ophthalmic use, providing targeted relief with minimal systemic absorption. Leos Eye Drop is typically administered as one to two drops in the affected eye(s) two to four times daily, or as directed by a healthcare professional. It is contraindicated in patients with active ocular infections caused by bacteria, fungi, or viruses, as corticosteroids may exacerbate these conditions. Caution is advised in patients with glaucoma or a history of steroid-induced intraocular pressure elevation, necessitating regular intraocular pressure monitoring during therapy. Common adverse effects may include transient burning or stinging upon instillation, increased intraocular pressure, and, rarely, cataract formation with prolonged use. Leos Eye Drop should be used under medical supervision, adhering strictly to prescribed dosage and duration to minimize risks and ensure optimal therapeutic outcomes.